Get started
ORTHOCELL LIMITEDORTHOCELL LIMITEDORTHOCELL LIMITED

ORTHOCELL LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

OCC chart


Full chart

OCC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪358.12 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.015 AUD
Net income (FY)
‪−7.18 M‬ AUD
Revenue (FY)
‪5.32 M‬ AUD
Shares float
‪187.69 M‬
Beta (1Y)
1.29

About ORTHOCELL LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Paul Frederick Anderson
Website
orthocell.com
Headquarters
Murdoch
Founded
2006
ISIN
AU000000OCC6
FIGI
BBG006N6HL75
Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. Its products include CelGro, which is a naturally derived collagen medical device for soft tissue repair; and Antilogous Tenocyte Implantation for chronic treatment resistant tendon injuries. The company was founded by Paul Frederick Anderson and Ming Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OCC news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OCC.

Frequently Asked Questions


The current price of OCC is 1.575 AUD — it has increased by 6.42% in the past 24 hours. Watch ORTHOCELL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ORTHOCELL LIMITED stocks are traded under the ticker OCC.
OCC stock has risen by 7.14% compared to the previous week, the month change is a 25.00% rise, over the last year ORTHOCELL LIMITED has showed a 303.85% increase.
We've gathered analysts' opinions on ORTHOCELL LIMITED future price: according to them, OCC price has a max estimate of 0.97 AUD and a min estimate of 0.97 AUD. Watch OCC chart and read a more detailed ORTHOCELL LIMITED stock forecast: see what analysts think of ORTHOCELL LIMITED and suggest that you do with its stocks.
OCC reached its all-time high on Feb 5, 2025 with the price of 1.790 AUD, and its all-time low was 0.105 AUD and was reached on Apr 23, 2019. View more price dynamics on OCC chart.
See other stocks reaching their highest and lowest prices.
OCC stock is 8.14% volatile and has beta coefficient of 1.29. Track ORTHOCELL LIMITED stock price on the chart and check out the list of the most volatile stocks — is ORTHOCELL LIMITED there?
Today ORTHOCELL LIMITED has the market capitalization of ‪358.12 M‬, it has increased by 13.22% over the last week.
Yes, you can track ORTHOCELL LIMITED financials in yearly and quarterly reports right on TradingView.
ORTHOCELL LIMITED is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
ORTHOCELL LIMITED revenue for the last half-year amounts to ‪2.41 M‬ AUD, despite the estimated figure of ‪4.20 M‬ AUD. In the next half-year revenue is expected to reach ‪4.60 M‬ AUD.
OCC net income for the last half-year is ‪−1.30 M‬ AUD, while the previous report showed ‪−1.95 M‬ AUD of net income which accounts for 33.57% change. Track more ORTHOCELL LIMITED financial stats to get the full picture.
No, OCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORTHOCELL LIMITED EBITDA is ‪−10.40 M‬ AUD, and current EBITDA margin is −210.03%. See more stats in ORTHOCELL LIMITED financial statements.
Like other stocks, OCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORTHOCELL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORTHOCELL LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORTHOCELL LIMITED stock shows the buy signal. See more of ORTHOCELL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.